To clarify, Emvision are taking the 510k pathway rather than De Novo . Previous company presentations had the FDA 510ķ clearance for Gen 1 in FY25. My understanding is it's simpler, faster and cheaper.
Ann: First Responder Device Unveiled, page-16
Add EMV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.06 |
Change
0.050(2.49%) |
Mkt cap ! $176.1M | |||
| Open | High | Low | Value | Volume |
| $2.05 | $2.08 | $2.01 | $153.3K | 75.17K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 4871 | $2.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.17 | 4000 | 1 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| EMV (ASX) Chart |